Investment Legend 👑
@EngineerStockks
Investing in IPOs & Stocks | B.E. in I.C. | Ex-IT Engineer | Financial Advisor | FIRE | Follow for IPOs | SME | GMP | Investments | Stocks Updates
#Brigade hotel #IPO Anchor Book ⚓ Ok kind with moderate demand Nothing extraordinary.. ▪︎ Motilal ▪︎ 360 One ▪︎ Franklin ▪︎ Edelweiss ▪︎ SBI ▪︎ Axis ▪︎ Nuvama
#Bajaj Housing Finance Q1 Result Good set with stable growth ▫️AUM growth 24% ▫️GNPA : 0.30 vs 0.29 NNPA : 0.13 vs 0.11 Overall Asset quality stable ▫️NIM : 4% stable ▫️Latest Price/Book : 4.95
#Indiqube Space #IPO Anchor Book⚓ Fari enough with good mix of fund houses & fair demand👍🏻 Few Marquee funds participation is missing , which looks below my expectations.. ▫️Malabar ▫️Motilal ▫️Whiteoak ▫️Edelweiss ▫️Invesco ▫️Societe ▫️Citi ▫️Groww
#GNG Electronics #IPO Anchor Book⚓ Good quality funds with nice demand✅ Size is < 500 cr still big funds like Goldman & other FII invested induces confidence🔥🔥 ▫️Goldman Sachs ▫️Bengal Finance @LuckyInvest_ARK ▫️Niveshaay @niveshaay ▫️Motilal ▫️Edelweiss ▫️Buoyant etc
#Anthem Bio science #IPO #Listing 🟩 Listed at ₹723 with 27% gain💰 IPO price : ₹570 Very Good & Blockbuster Listing 🔥💥
#Anthem Biosciences #IPO #Final Decision 🟩 Applying for listing gain & medium term ▫️Best amongst all CRDMO cos. with strong drug R&D & mfg capabilities ▫️Strong cash flows & low debt ▫️Globally 287 customers across 44 countries ▫️Highly skilled team of 1015 Scientific &
#Anthem Bio #IPO #QIB Full list⤵️
#Anthem Bio #IPO #QIB Full list👇🏻 One of the best & diversified list, Seems no one missed to participate ; ) Strong demand from all funds : ▫️Goldman Sachs ▫️Nomura ▫️Citi ▫️MS ▫️Fidelity ▫️CLSA ▫️Societe ▫️Ghisallo ▫️Whiteoak ▫️ICICI ▫️LIC ▫️Motilal ▫️Kotak ▫️HDFC ▫️Tata Etc
#Anthem Bio #IPO #QIB Full list⤵️
#Anthem Bio #IPO #QIB Full list👇🏻 One of the best & diversified list, Seems no one missed to participate ; ) Strong demand from all funds : ▫️Goldman Sachs ▫️Nomura ▫️Citi ▫️MS ▫️Fidelity ▫️CLSA ▫️Societe ▫️Ghisallo ▫️Whiteoak ▫️ICICI ▫️LIC ▫️Motilal ▫️Kotak ▫️HDFC ▫️Tata Etc
#Anthem Bio #IPO #QIB Full list👇🏻 One of the best & diversified list, Seems no one missed to participate ; ) Strong demand from all funds : ▫️Goldman Sachs ▫️Nomura ▫️Citi ▫️MS ▫️Fidelity ▫️CLSA ▫️Societe ▫️Ghisallo ▫️Whiteoak ▫️ICICI ▫️LIC ▫️Motilal ▫️Kotak ▫️HDFC ▫️Tata Etc
#Anthem Biosciences #IPO #Subscription QIB ₹ 1,30,592 Cr🔥💥 💰Recent best QIBs list ▫️Bajaj : 2,60,239 Cr ▫️Waaree : 1,83,055 Cr ▫️Vishal : 1,36,176 Cr ▫️HDB Fin : 1,31,696 Cr ▫️#Anthem : 1,30,592 Cr🔥🔥 🟩 Allotment : Retail 1 : 4 SHNI 1 : 29 BHNI 1 : 10 All The Best🙏🏻
#Anthem Biosciences #IPO #Final Decision 🟩 Applying for listing gain & medium term ▫️Best amongst all CRDMO cos. with strong drug R&D & mfg capabilities ▫️Strong cash flows & low debt ▫️Globally 287 customers across 44 countries ▫️Highly skilled team of 1015 Scientific &
#Anthem Biosciences #IPO #Final take ⤵️
#Anthem Biosciences #IPO #Final Decision 🟩 Applying for listing gain & medium term ▫️Best amongst all CRDMO cos. with strong drug R&D & mfg capabilities ▫️Strong cash flows & low debt ▫️Globally 287 customers across 44 countries ▫️Highly skilled team of 1015 Scientific &
#Anthem Biosciences #IPO #Final take ⤵️
#Anthem Biosciences #IPO #Final Decision 🟩 Applying for listing gain & medium term ▫️Best amongst all CRDMO cos. with strong drug R&D & mfg capabilities ▫️Strong cash flows & low debt ▫️Globally 287 customers across 44 countries ▫️Highly skilled team of 1015 Scientific &
#Anthem Biosciences #IPO #Final take ⤵️
#Anthem Biosciences #IPO #Final Decision 🟩 Applying for listing gain & medium term ▫️Best amongst all CRDMO cos. with strong drug R&D & mfg capabilities ▫️Strong cash flows & low debt ▫️Globally 287 customers across 44 countries ▫️Highly skilled team of 1015 Scientific &
#HDB Fin #Q1 Result ▫️AUM : 1,09,690 cr up 14.7% ▫️NII : 2092 cr Up 18.3% ▫️PAT 568 cr Down -2.4% QoQ 7% Up ▫️Book Value ₹225.4 P/B : 3.73 Margin Expansion driving profit up QoQ Decent AUM growth Valuations reasonable ▫️Peers P/B Bajaj : 6 Chola : 5.5 Sundaram : 4.3
#Smartworks Coworking #IPO I'm NOT taking any risk in this as demand is also very negligible & the company doesn't look promising as stated in review. Listing gains are not encouraging in mainboard Will post about Anthem biosciences soon... Note : Personal view DYDD
#Smartworks Coworking #IPO Final Decision ⬜ Neutral - only risk takers can apply for listing gain ▫️Good Oparating cash flows ▫️Established brand with strong client base of Google, L&T, Philips, Persistent etc Negatives : ▫️Fully priced Valuations ▫️Few litigation &
#Travel Food Services #TFS IPO Listed at 1125 ₹ with 2.2% gain Small listing gain was expected so performed as per expectations. Now trading near par. I'm holding few shares for long term perspective
#Travel Food #IPO #Final Decision Apply 🟩 for Long term with small listing gain exp. ▫️Market leader with 45% lounge & 26% in QSR airport biz share in india ▫️Consistent cash flows & OPM ▫️Debt free with cash reserves ▫️Valuations at premium but reasonable than peers like-
#Travel Food Services #TFS IPO QIB allotment list⤵️ Major allotment with strong💪🏻 institutional funds : ▫️Bofa Sec. ▫️Goldman sachs ▫️Schroder (UK based) ▫️Societe ▫️Copthall ⚓Additional stake increase by Anchors ▫️ADIA ▫️Fidelity ▫️Samsung ▫️Whiteoak ▫️ICICI ▫️Tata & More
